Clinical medicine

• Relationship between cannabis use frequency and major depressive disorder in adolescents: findings from the National Survey on Drug Use and Health 2012–2017 (30 Sep 2024)
  
• Online Patient-Provider Cannabis Consultations (30 Sep 2024)
  
• Medicinal cannabis for psychiatric disorders: a clinically-focused systematic review (30 Sep 2024)
  
• Cannabidiol for Viral Diseases: Hype or Hope? (27 Sep 2024)
  
• An Evaluation of Regulatory Regimes of Medical Cannabis: What Lessons Can Be Learned for the UK? (27 Sep 2024)
  
• Therapeutic use of cannabis and cannabinoids: an evidence mapping and appraisal of systematic reviews (26 Sep 2024)
  
• Cannabinoids in the Older Person: A Literature Review (26 Sep 2024)
  
• The Void in Clinician Counseling of Cannabis Use (24 Sep 2024)
  
• The therapeutic role of Cannabidiol in mental health: a systematic review (24 Sep 2024)
  
• Introduction to Cannabis Special Issue (24 Sep 2024)
  
• Cannabis and autism, explained (24 Sep 2024)
  
• A population-based survey to assess the association between cannabis and quality of life among colorectal cancer survivors (24 Sep 2024)
  
• Synthetic Cannabinoids: An Emerging Cause of Coagulopathy (17 Sep 2024)
  
• The role of cannabinoids in epilepsy treatment: a critical review of efficacy results from clinical trials (16 Sep 2024)
  
• Review of Medicinal Use of Cannabis Derivatives and the Societal Impact of Legalization (16 Sep 2024)
  
• Regulation and marketing of cannabidiol-containing products in European countries. Pharmacists’ knowledge in Bulgaria (16 Sep 2024)
  
• Pharmacology and drug interactions of cannabinoids (16 Sep 2024)
  
• Medical cannabis for orthopaedic patients with chronic musculoskeletal pain: does evidence support its use? (16 Sep 2024)
  
• Is cannabidiol hepatotoxic or hepatoprotective: A review (16 Sep 2024)
  
• Impact of Cannabis Use on Brain Structure and Function in Suppressed HIV Infection (16 Sep 2024)
  
• Epidiolex (Cannabidiol) Primer: Frequently Asked Questions for Patients and Caregivers (16 Sep 2024)
  
• Ending the pain of children with severe epilepsy? An audit of the impact of medical cannabis in 10 patients (16 Sep 2024)
  
• Effects of standardized Cannabis sativa extract and ionizing radiation in melanoma cells in vitro (16 Sep 2024)
  
• Commercial Cannabidiol Caution: A New Gold Rush (16 Sep 2024)
  
• Cannabis hyperemesis syndrome: an update on the pathophysiology and management (16 Sep 2024)
  
• Cannabinoids as an Alternative Option for Conventional Analgesics in Cancer Pain Management: A Pharmacogenomics Perspective (16 Sep 2024)
  
• Cannabidiol for Treating Lennox-Gastaut Syndrome and Dravet Syndrome in Korea (16 Sep 2024)
  
• Can prescribed medical cannabis use reduce the use of other more harmful drugs? (16 Sep 2024)
  
• Association of early onset of cannabis, cigarette, other drug use and schizophrenia or psychosis (16 Sep 2024)
  
• Adverse events following cannabis for medical use in Tuscany: An analysis of the Italian Phytovigilance database (16 Sep 2024)
  
• A Scoping Review on Clinical Trials of Pain Reduction With Cannabis Administration in Adults (16 Sep 2024)
  
• Examining the moderating role of cannabis use on the relationship between alcohol consumption and inflammation in individuals with alcohol use disorder (03 Sep 2024)
  
• Efficacy of cannabinoids compared to the current standard treatments on symptom relief in persons with multiple sclerosis (CANSEP trial): study protocol for a randomized clinical trial (03 Sep 2024)
  
• Cannabinoids and triple-negative breast cancer treatment (03 Sep 2024)
  
• Unveiling the Potential of Cannabinoids in Multiple Sclerosis and the Dawn of Nano-Cannabinoid Medicine (02 Sep 2024)
  
• Trends of emergency department visits for cannabinoid hyperemesis syndrome in Nevada: An interrupted time series analysis (02 Sep 2024)
  
• Trends in prescription and cost of Sativex, a cannabinoid-based medicine, in treating patients with multiple sclerosis in England (02 Sep 2024)
  
• Potential perioperative cardiovascular outcomes in cannabis/cannabinoid users. A call for caution (02 Sep 2024)
  
• Patients’ perspectives on prescription cannabinoid therapies: a cross-sectional, exploratory, anonymous, one-time web-based survey among German patients (02 Sep 2024)
  
• Oral Tetrahydrocannabinol (THC):Cannabinoid (CBD) Cannabis Extract Adjuvant for Reducing Chemotherapy-Induced Nausea and Vomiting (CINV): A Randomized, Double-Blinded, Placebo-Controlled, Crossover Tr (02 Sep 2024)
  
• Morphine Analgesia, Cannabinoid Receptor 2, and Opioid Growth Factor Receptor Cancer Tissue Expression Improve Survival after Pancreatic Cancer Surgery (02 Sep 2024)
  
• Heterogeneity in hormone-dependent breast cancer and therapy: Steroid hormones, HER2, melanoma antigens, and cannabinoid receptors (02 Sep 2024)
  
• Drug–Cannabinoid Interactions in Selected Therapeutics for Symptoms Associated with Epilepsy, Autism Spectrum Disorder, Cancer, Multiple Sclerosis, and Pain (02 Sep 2024)
  
• Case report: Cannabinoid therapy for discoid lupus erythematosus in a dog (02 Sep 2024)
  
• Cannabis Hyperemesis Syndrome: What Do We Know? (02 Sep 2024)
  
• Cannabinoid receptor 2 signal promotes type 2 immunity in the lung (02 Sep 2024)
  
• Cannabinoid products for pain management: recommendations from the São Paulo State Society of Anesthesiology (02 Sep 2024)
  
• Cannabinoid levels description in a cohort of patients with chronic and neuropathic pain treated with Cannabis decoction: A possible role of TDM (02 Sep 2024)
  
• Beyond prediction: unveiling the prognostic power of μ-opioid and cannabinoid receptors, alongside immune mediators, in assessing the severity of SARS-CoV-2 infection (02 Sep 2024)
  
• Beta-Caryophyllene, a Cannabinoid Receptor Type 2 Selective Agonist, in Emotional and Cognitive Disorders (02 Sep 2024)
  
• An answered call for aid? Cannabinoid clinical framework for the opioid epidemic (02 Sep 2024)
  
• Overexpression of cannabinoid receptor 2 is associated with human breast cancer proliferation, apoptosis, chemosensitivity and prognosis via the PI3K/Akt/mTOR signaling pathway (30 Aug 2024)
  
• cancer pain: an analysis of pain mechanism and cannabinoid profile (30 Aug 2024)
  
• The Anti-Tumorigenic Role of Cannabinoid Receptor 2 in Colon Cancer: A Study in Mice and Humans (29 Aug 2024)
  
• Mediators of Placebo Response to Cannabinoid Treatment in Children with Autism Spectrum Disorder (29 Aug 2024)
  
• Influence of Cannabinoid Treatment on Trajectories of Patient-Related Outcomes in Chronic Pain: Pain Intensity, Emotional Distress, Tolerability and Physical Disability (29 Aug 2024)
  
• Editorial: Appropriateness and safety of using cannabinoid and psychedelic medicines as treatments for psychiatric disorders (29 Aug 2024)
  
• Cannabis and cannabinoid medications for the treatment of chronic orofacial pain: A scoping review (29 Aug 2024)
  
• Cannabinoid-Based Ocular Therapies and Formulations (29 Aug 2024)
  
• Synthetic cannabinoid for the treatment of severe chronic noncancer pain in children and adolescents (28 Aug 2024)
  
• Cannabinoid receptor 2 plays a pro-tumorigenic role in non-small cell lung cancer by limiting anti-tumor activity of CD8+ T and NK cells (28 Aug 2024)
  
• Therapeutic Use of Cannabis in Inflammatory Bowel Disease (27 Aug 2024)
  
• The Cytotoxic Effect of Isolated Cannabinoid Extracts on Polypoid Colorectal Tissue (27 Aug 2024)
  
• Patient-Related Barriers to the Prescription of Cannabinoid-Based Medicines in Palliative Care: A Qualitative Approach (27 Aug 2024)
  
• Evaluation of cannabinoid receptors type 1–2 in periodontitis patients (27 Aug 2024)
  
• Cannabinoid Therapeutic Effects in Inflammatory Bowel Diseases: A Systematic Review and Meta-Analysis of Randomized Controlled Trials (27 Aug 2024)
  
• Cannabinoid hyperemesis syndrome and cannabis withdrawal syndrome: a review of the management of cannabis-related syndrome in the emergency department (27 Aug 2024)
  
• Cannabinoid Conference 2022 (27 Aug 2024)
  
• Potential Role of Cannabinoid Type 2 Receptors in Neuropsychiatric and Neurodegenerative Disorders (25 Aug 2024)
  
• Cannabinoid extract in microdoses ameliorates mnemonic and nonmnemonic Alzheimer’s disease symptoms: a case report (25 Aug 2024)
  
• Cannabinoid Effect and Safety in Spasticity Following Stroke: A Double-Blind Randomized Placebo-Controlled Study (25 Aug 2024)
  
• A bibliometric analysis of the cannabis and cannabinoid research literature (25 Aug 2024)
  
• New Insights and Potential Therapeutic Targeting of CB2 Cannabinoid Receptors in CNS Disorders (21 Aug 2024)
  
• Neurological Benefits, Clinical Challenges, and Neuropathologic Promise of Medical Marijuana: A Systematic Review of Cannabinoid Effects in Multiple Sclerosis and Experimental Models of Demyelination (21 Aug 2024)
  
• Interplay between the Cannabinoid System and microRNAs in Cancer (21 Aug 2024)
  
• Impact of Cannabinoid Compounds on Skin Cancer (21 Aug 2024)
  
• Cannabinoid interventions for improving cachexia outcomes in cancer: a systematic review and meta‐analysis (21 Aug 2024)
  
• Safety Considerations in Cannabinoid-Based Medicine (20 Aug 2024)
  
• Pros and Cons of the Cannabinoid System in Cancer: Focus on Hematological Malignancies (20 Aug 2024)
  
• Plant-derived natural therapeutics targeting cannabinoid receptors in metabolic syndrome and its complications: A review (20 Aug 2024)
  
• Peripheral Endogenous Cannabinoid Levels Are Increased in Schizophrenia Patients Evaluated in a Psychiatric Emergency Setting (20 Aug 2024)
  
• Medicinal Cannabis and Synthetic Cannabinoid Use (20 Aug 2024)
  
• Cannabinoid treatment for autism: a proof-of-concept randomized trial (20 Aug 2024)
  
• Cannabinoid Receptor Type-2 in B Cells Is Associated with Tumor Immunity in Melanoma (20 Aug 2024)
  
• Cannabinoid Drugs-Related Neuroprotection as a Potential Therapeutic Tool Against Chemotherapy-Induced Cognitive Impairment (20 Aug 2024)
  
• Cannabinoid as Beneficial Replacement Therapy for Psychotropics to Treat Neuropsychiatric Symptoms in Severe Alzheimer’s Dementia: A Clinical Case Report (20 Aug 2024)
  
• Cannabidiol oxidation product HU-331 is a potential anticancer cannabinoid-quinone: a narrative review (20 Aug 2024)
  
• Activation of Cannabinoid Receptor 2 Prevents Colitis-Associated Colon Cancer through Myeloid Cell De-activation Upstream of IL-22 Production (20 Aug 2024)
  
• A focused review on CB2 receptor-selective pharmacological properties and therapeutic potential of β-caryophyllene, a dietary cannabinoid (20 Aug 2024)
  
• Cannabinoid Delivery Systems for Pain and Inflammation Treatment (19 Aug 2024)
  
• Antitumor Cannabinoid Chemotypes: Structural Insights (19 Aug 2024)
  
• Targeting Cannabinoid Signaling in the Immune System: “High”-ly Exciting Questions, Possibilities, and Challenges (18 Aug 2024)
  
• Synthetic and Non-synthetic Cannabinoid Drugs and Their Adverse Effects-A Review From Public Health Prospective (18 Aug 2024)
  
• Focus on the Endogenous Cannabinoid System in Migraine (18 Aug 2024)
  
• Clinical characteristics of synthetic cannabinoid-induced psychosis in relation to schizophrenia: a single-center cross-sectional analysis of concurrently hospitalized patients (18 Aug 2024)
  
• Case Series of Synthetic Cannabinoid Intoxication from One Toxicology Center (18 Aug 2024)
  
• Cannabidiol, among Other Cannabinoid Drugs, Modulates Prepulse Inhibition of Startle in the SHR Animal Model: Implications for Schizophrenia Pharmacotherapy (18 Aug 2024)
  
• First-Episode of Synthetic Cannabinoid-Induced Psychosis in a Young Adult, Successfully Managed with Hospitalization and Risperidone (12 Aug 2024)
  
• Systematic review of drug-drug interactions of delta-9-tetrahydrocannabinol, cannabidiol, and Cannabis (24 May 2024)
  
• Phytocannabinoids: Exploring Pharmacological Profiles and Their Impact on Therapeutical Use (24 May 2024)
  
• Medicinal Cannabis (MedCan 3): a randomised, multicentre, double-blind, placebo-controlled trial to assess THC/CBD (1:20) to relieve symptom burden in patients with cancer—a study protocol for a rando (24 May 2024)
  
• Inflammation and cancer: friend or foe? (24 May 2024)
  
• CBD and THC in Special Populations: Pharmacokinetics and Drug–Drug Interactions (24 May 2024)
  
• Cannabis and cancer: unveiling the potential of a green ally in breast, colorectal, and prostate cancer (24 May 2024)
  
• Plant-Based Cannabinoids for the Treatment of Chronic Neuropathic Pain (13 May 2024)
  
• Cannabinoids in Medicine: A Multifaceted Exploration of Types, Therapeutic Applications, and Emerging Opportunities in Neurodegenerative Diseases and Cancer Therapy (13 May 2024)
  
• A Systematic Review on Cannabinoids for Neuropathic Pain Administered by Routes Other than Oral or Inhalation (13 May 2024)
  
• Effects of Cannabidiol on Innate Immunity: Experimental Evidence and Clinical Relevance (27 Feb 2023)
  
• Beyond Pain Relief: A Review on Cannabidiol Potential in Medical Therapies (27 Feb 2023)
  
• CB2 Cannabinoid Receptors Contribute to Bacterial Invasion and Mortality in Polymicrobial Sepsis (27 Nov 2022)
  
• The Endocannabinoid System as a Pharmacological Target for New Cancer Therapies (05 Sep 2022)
  
• Major Phytocannabinoids and Their Related Compounds: Should We Only Search for Drugs That Act on Cannabinoid Receptors? (05 Sep 2022)
  
• Editorial: The Endocannabinoid System: Filling the Translational Gap Between Neuroscience and Psychiatry (05 Sep 2022)
  
• CB2 Receptor Involvement in the Treatment of Substance Use Disorders (05 Sep 2022)
  
• Cannabidiol Induces Cell Death in Human Lung Cancer Cells and Cancer Stem Cells (05 Sep 2022)
  
• A potential role for cannabichromene in modulating TRP channels during acute respiratory distress syndrome - Journal of Cannabis Research (05 Sep 2022)
  
• Minor Cannabinoids: Biosynthesis, Molecular Pharmacology and Potential Therapeutic Uses (01 Sep 2022)
  
• Gene Expression Data Mining Reveals the Involvement of GPR55 and Its Endogenous Ligands in Immune Response, Cancer, and Differentiation (01 Sep 2022)
  
• Endocannabinoid Anandamide Attenuates Acute Respiratory Distress Syndrome through Modulation of Microbiome in the Gut-Lung Axis (01 Sep 2022)
  
• Editorial: Challenges and Conundrums in Cannabinoid-Based Treatments for Epilepsy Syndromes and Associated Neurobehavioral Comorbidities (01 Sep 2022)
  
• The strengths and limits of cannabinoids and their receptors in cancer: Insights into the role of tumorigenesis-underlying mechanisms and therapeutic aspects (27 Aug 2022)
  
• Cannabinoids in Medicine: Cancer, Immunity, and Microbial Diseases (27 Aug 2022)
  
• Antimicrobial and Antiviral (SARS-CoV-2) Potential of Cannabinoids and Cannabis sativa: A Comprehensive Review (27 Aug 2022)
  
• Considerations for Cannabinoids in Perioperative Care by Anesthesiologists (13 Aug 2022)
  
• Components of the Endocannabinoid System and Effects of Cannabinoids Against Bone Diseases: A Mini-Review (13 Aug 2022)
  
• A Phase I Trial to Determine the Pharmacokinetics, Psychotropic Effects, and Safety Profile of a Novel Nanoparticle-Based Cannabinoid Spray for Oromucosal Delivery (07 Aug 2022)
  
• The Transdermal Delivery of Therapeutic Cannabinoids (05 Aug 2022)
  
• Targeting the Endocannabinoidome in Pancreatic Cancer (05 Aug 2022)
  
• Medical Cannabis in Pediatric Oncology: Friend or Foe? (05 Aug 2022)
  
• Comparison of nabiximols versus oral dronabinol for pain (05 Aug 2022)
  
• Clinical Data on Canabinoids: Translational Research in the Treatment of Autism Spectrum Disorders (05 Aug 2022)
  
• Botanically-Derived Δ9-Tetrahydrocannabinol and Cannabidiol, and Their 1:1 Combination, Modulate Toll-like Receptor 3 and 4 Signalling in Immune Cells from People with Multiple Sclerosis (05 Aug 2022)
  
• A Low Dose of Pure Cannabidiol Is Sufficient to Stimulate the Cytotoxic Function of CIK Cells without Exerting the Downstream Mediators in Pancreatic Cancer Cells (05 Aug 2022)
  
• A Cannabinoid 2-Selective Agonist Inhibits Allogeneic Skin Graft Rejection In Vivo (05 Aug 2022)
  
• The Endocannabinoid System: A Potential Therapeutic Target for Coagulopathies (31 Jul 2022)
  
• South African Family Practice (31 Jul 2022)
  
• Safety and efficacy of cannabidiol-cannabidiolic acid rich hemp extract in the treatment of refractory epileptic seizures in dogs (31 Jul 2022)
  
• Medicinal Cannabis and Central Nervous System Disorders (31 Jul 2022)
  
• Medical cannabis in treating patients with sleep disorders (31 Jul 2022)
  
• Mechanisms of Cannabidiol (CBD) in Cancer Treatment: A Review (31 Jul 2022)
  
• In Vitro Effect of Δ9-Tetrahydrocannabinol and Cannabidiol on Cancer-Associated Fibroblasts Isolated from Lung Cancer (31 Jul 2022)
  
• Endocannabinoid Modulation in Neurodegenerative Diseases: In Pursuit of Certainty (31 Jul 2022)
  
• Effect of combining CBD with standard breast cancer therapeutics (31 Jul 2022)
  
• Cannabinoids for the Treatment of Dermatologic Conditions (31 Jul 2022)
  
• Cannabinoid extract in microdoses ameliorates mnemonic and nonmnemonic Alzheimer’s disease symptoms: a case report - Journal of Medical Case Reports (31 Jul 2022)
  
• A critical review of cannabis in medicine and dentistry: A look back and the path forward (31 Jul 2022)
  
• What are the informational pathways that shape people’s use of cannabidiol for medical purposes? - Journal of Cannabis Research (26 Jul 2022)
  
• The use and effects of synthetic cannabinoid receptor agonists by New South Wales cannabis treatment clients - Journal of Cannabis Research (26 Jul 2022)
  
• The therapeutic role of Cannabidiol in mental health: a systematic review - Journal of Cannabis Research (26 Jul 2022)
  
• The in vitro effect of delta-9-tetrahydrocannabinol and cannabidiol on whole blood viscosity, elasticity and membrane integrity - Journal of Cannabis Research (26 Jul 2022)
  
• Staff awareness of the use of cannabidiol (CBD): a trust-wide survey study in the UK - Journal of Cannabis Research (26 Jul 2022)
  
• Reasons for cannabidiol use: a cross-sectional study of CBD users, focusing on self-perceived stress, anxiety, and sleep problems - Journal of Cannabis Research (26 Jul 2022)
  
• Online information on medical cannabis is not always aligned with scientific evidence and may raise unrealistic expectations - Journal of Cannabis Research (26 Jul 2022)
  
• Medicinal cannabis: knowledge, beliefs, and attitudes of Colombian psychiatrists - Journal of Cannabis Research (26 Jul 2022)
  
• Medical cannabis for the treatment of fibromyalgia syndrome: a retrospective, open-label case series - Journal of Cannabis Research (26 Jul 2022)
  
• Feline cognitive dysfunction as a model for Alzheimer’s disease in the research of CBD as a potential treatment—a narrative review - Journal of Cannabis Research (26 Jul 2022)
  
• Endothelial dysfunction and angiogenesis: what is missing from COVID-19 and cannabidiol story? - Journal of Cannabis Research (26 Jul 2022)
  
• CBD-enriched cannabis for autism spectrum disorder: an experience of a single center in Turkey and reviews of the literature - Journal of Cannabis Research (26 Jul 2022)
  
• Cannabidiol use and effectiveness: real-world evidence from a Canadian medical cannabis clinic - Journal of Cannabis Research (26 Jul 2022)
  
• Cannabidiol oxidation product HU-331 is a potential anticancer cannabinoid-quinone: a narrative review - Journal of Cannabis Research (26 Jul 2022)
  
• Anti-cancer properties of cannflavin A and potential synergistic effects with gemcitabine, cisplatin, and cannabinoids in bladder cancer - Journal of Cannabis Research (26 Jul 2022)
  
• Study Shows Cannabinoids May Help With Pathological Tremors (25 Jul 2022)
  
• Study reveals antibiotic potential of cannabis compound (25 Jul 2022)
  
• Exploring cannabinoid bioavailability in the medical cannabis industry (25 Jul 2022)
  
• Combination of cannabidiol with low‑dose naltrexone increases the anticancer action of chemotherapy in vitro and in vivo (25 Jul 2022)
  
• Research Breakthrough: Cannabis & Autism (21 Jul 2022)
  
• Medical Uses of CBD (21 Jul 2022)
  
• ICRS 2019: CBD for Anxiety, Cancer, Heart Disease, Addiction... (21 Jul 2022)
  
• Gut Microbiota & the Endocannabinoid System (21 Jul 2022)
  
• Endocannabinoid System as a Promising Therapeutic Target in Inflammatory Bowel Disease – A Systematic Review (21 Jul 2022)
  
• Encouraging Cancer Research (21 Jul 2022)
  
• CBD User's Guide (21 Jul 2022)
  
• CBD Dentistry (21 Jul 2022)
  
• CBD & Cannabis for Endometriosis (21 Jul 2022)
  
• Cannabis & the Immune System: A Complex Balancing Act (21 Jul 2022)
  
• Cannabis and Cannabinoids (PDQ®)–Patient Version (21 Jul 2022)
  
• Cannabis and Cannabinoids (PDQ®)–Health Professional Version (21 Jul 2022)
  
• Cannabis and Cancer Part 2: Scientists Look for Ways to Increase Knowledge About Cannabis with Help from People with Cancer (21 Jul 2022)
  
• Cannabis and Cancer, Part 1: Despite Lack of Evidence, Cannabis Products Being Widely Used (21 Jul 2022)
  
• A mixed methods analysis of cannabis use routines for chronic pain management - Journal of Cannabis Research (21 Jul 2022)
  
• What is CBD? Definition of Cannabidiol & CBD Oil (20 Jul 2022)
  
• The Science of Cannabinoids (20 Jul 2022)
  
• Single Compound vs. Whole Plant CBD (20 Jul 2022)
  
• How to use CBD & Cannabis (20 Jul 2022)
  
• CBIS Cannabinoid Research (20 Jul 2022)
  
• Cannabis Therapy for Seizures in Animals (20 Jul 2022)
  
• What Is HHC? (18 Jul 2022)
  
• What is Cannabichromene (CBC)? Benefits, Uses, Dosages (18 Jul 2022)
  
• What are cannabinoids CBN, CBC, CBG and THCV? (18 Jul 2022)
  
• Very high doses of CBD, a cannabis component, don’t affect driving (18 Jul 2022)
  
• Top Delta-8 THC Questions Answered by CBD Science (18 Jul 2022)
  
• Top CBN (Cannabinol) Questions Answered by CBD Science (18 Jul 2022)
  
• Top CBL Questions Answered by CBD Science (18 Jul 2022)
  
• Top CBGA Questions Answered by CBD Science (18 Jul 2022)
  
• Top CBG (Cannabigerol) Questions Answered by CBD Science (18 Jul 2022)
  
• Top CBDA (Cannabidiolic Acid) Questions Answered by CBD Science (18 Jul 2022)
  
• Top CBD (Cannabidiol) Questions Answered by CBD Science (18 Jul 2022)
  
• The Science Behind CBD's Effects on the Brain and Body (18 Jul 2022)
  
• Tablet containing CBD shows promise in reducing post-operative pain (18 Jul 2022)
  
• Substance analogous to cannabidiol can enhance chemotherapy by preventing neuropathic pain (18 Jul 2022)
  
• Study provides insights on the effects of cannabidiol on severe form of epilepsy (18 Jul 2022)
  
• Some cannabis products associated with short-term chronic pain improvements, but side effects a concern (18 Jul 2022)
  
• Prescribed CBD could help people quit cannabis (18 Jul 2022)
  
• Pioneering clinical trial to treat psychosis in Parkinson's patients using cannabidiol (18 Jul 2022)
  
• New study: Cannabis helps fight resistant bacteria (18 Jul 2022)
  
• New insight into how cannabidiol takes effect in the brains of people with psychosis (18 Jul 2022)
  
• Medicinal cannabis may reduce behavioral problems in kids with intellectual disabilities (18 Jul 2022)
  
• Kashanchi and Liotta studying effect of cannabidiol on exosome release (18 Jul 2022)
  
• Here’s the truth about CBD, from a cannabis researcher (18 Jul 2022)
  
• Guide to Cannabinoids: Understanding the Endocannabinoid System (18 Jul 2022)
  
• Epileptic seizure frequency fell by 86% in kids treated with whole plant medicinal cannabis (18 Jul 2022)
  
• Daily use of cannabidiol (‘CBD’) oil may be linked to lung cancer regression (18 Jul 2022)
  
• Customized Phytocannabinoid Profiles: A Novel Source of Precision Therapeutics for Specific Cancer Subtypes? (18 Jul 2022)
  
• Cresco Labs (18 Jul 2022)
  
• Certain CBD oils no better than pure CBD at inhibiting certain cancer cell lines (18 Jul 2022)
  
• CBD shows promise for fighting aggressive brain cancer (18 Jul 2022)
  
• CBD reduces craving and anxiety in people with heroin use disorder (18 Jul 2022)
  
• CBD may help avert lung destruction in COVID-19 (18 Jul 2022)
  
• CBD and THC are Safe Supplements to Opioid Treatment (18 Jul 2022)
  
• Cannabis extract helps reset brain function in psychosis (18 Jul 2022)
  
• Cannabis compound acts as an antibiotic (18 Jul 2022)
  
• Cannabinoid Acids Breakthrough Study for COVID (18 Jul 2022)
  
• Cannabidivarin Definition (18 Jul 2022)
  
• Cannabidiol (CBD) in cannabis does not impair driving, landmark study shows (18 Jul 2022)
  
• Animal study shows safety of using CBD and THC with opioids (18 Jul 2022)
  
• 10 CBD facts every user should know (18 Jul 2022)